Marcia Belvin

SVP, Chief Scientific Officer

SVP, Chief Scientific Officer at CytomX Therapeutics, Inc., filing insider transactions on 2026-03-17.

Total Purchases

—

0 transactions

Total Sales

$202K

1 transaction

Companies Traded

1 total filings

Active Since

2026-03-17

Last: 2026-03-17

Companies

CytomX Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-17	CTMX	Sale	31.5K	$6.42	$202K	300.8K	SEC ↗